Medications

Study finds users prefer daily oral PrEP pill despite new options

When PrEP (pre-exposure prophylaxis), a drug that prevents HIV infection, was first approved by the FDA in 2012, it was a medical breakthrough that promised to drastically reduce HIV transmission. Traditionally, PrEP is administered ...

HIV & AIDS

Task force recommends PrEP for reducing risk for HIV acquisition

The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation forms the basis ...

HIV & AIDS

Examining HIV care services resilient during COVID-19 pandemic

The HIV prevention and care service was resilient during the COVID-19 pandemic, and services partially rebounded in quarter 3 (Q3) of 2020 following a decline in Q2, according to research published in the Dec. 2 issue of ...

page 2 from 7